AbCellera Biologics (ABCL) Earnings (2020 - 2026)
AbCellera Biologics (ABCL) earnings from Mar 31, 2020 to Mar 31, 2026. The TTM AbCellera Biologics (ABCL) earnings is -$144M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
AbCellera Biologics (ABCL) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -14.25% |
| 3 Years TTM | +42.11% |
Annual Earnings change of AbCellera Biologics (ABCL)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$43M | -70.52% |
| 2025 | -$146M | -10.10% |
| 2024 | -$163M | +11.24% |
| 2023 | -$146M | -192.35% |
| 2022 | $159M | +3.30% |
| 2021 | $153M | +29.04% |
| 2020 | $119M | -5481.00% |
| 2019 | -$2.21M | N/A |